This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, F. Articles by Huang, L. Search for Related Content PubMed PubMed Citation Articles by Zhou, F. Articles by Huang, L.

Prolonged Survival of Thymoma-bearing Mice after Vaccination with a Soluble Protein Antigen Entrapped in Liposomes: A Model Study¹

Departments of Biochemistry [F. Z., L. H.] and Microbiology [B. T. R.] and Cell, Molecular, and Developmental Biological Program [F. Z., B. T. R., L. H.], University of Tennessee, Knoxville, TN 37996-0840

EG7-OVA cells are mouse thymoma ELA cells stably transfected with the complementary DNA of chicken ovalbumin (OVA) and thus express OVA epitopes as a unique antigen. Cytotoxic T lymphocytes specific to OVA can be elicited by immunization of mice with OVA osmotically loaded into syngeneic splenocytes or entrapped in liposomes. Cytotoxic T lymphocytes thus induced can specifically cytolyse the EG7-OVA cells in vitro in an antigen-specific and major histocompatibility complex-restricted manner. In the present study, we have examined in this model system whether immunization with liposomal OVA can protect mice against tumors induced by EG7-OVA cells. Vaccination with OVA either entrapped in liposomes or osmotically loaded in the syngeneic splenocytes prolonged the survival of mice which had been challenged with EG7-OVA cells, but not those mice challenged with the parent EL4 cells. The antitumor effect was attributed to the induced OVA-specific cytotoxic T lymphocyte activity, since other forms of acquired immunity such as interaction of tumor cells with specific antibody could not be detected. Our results demonstrate that immunization with antigen incorporated in liposomes could be a useful means of inducing a protective antitumor response.

¹ This work was supported by Grants CA 24553, AI 29893, and AI 24762 from the NIH.

² Current address: Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

³ To whom requests for reprints should be addressed, at Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

Received 5/29/92. Accepted 9/ 4/92.

This article has been cited by other articles:

				S. Calbo, H. Delagreverie, C. Arnoult, F.-J. Authier, F. Tron, and O. Boyer Functional Tolerance of CD8+ T Cells Induced by Muscle-Specific Antigen Expression J. Immunol., July 1, 2008; 181(1): 408 - 417. [Abstract] [Full Text] [PDF]

				D.-E. Hu, S. O. M. Dyke, A. M. Moore, L. L. Thomsen, and K. M. Brindle Tumor Cell-Derived Nitric Oxide Is Involved in the Immune-Rejection of an Immunogenic Murine Lymphoma Cancer Res., January 1, 2004; 64(1): 152 - 161. [Abstract] [Full Text] [PDF]

				F. G. Gao, V. Khammanivong, W. J. Liu, G. R. Leggatt, I. H. Frazer, and G. J. P. Fernando Antigen-specific CD4+ T-Cell Help Is Required to Activate a Memory CD8+ T Cell to a Fully Functional Tumor Killer Cell Cancer Res., November 15, 2002; 62(22): 6438 - 6441. [Abstract] [Full Text] [PDF]

				G. G. Chikh, S. Kong, M. B. Bally, J.-C. Meunier, and M.-P. M. Schutze-Redelmeier Efficient Delivery of Antennapedia Homeodomain Fused to CTL Epitope with Liposomes into Dendritic Cells Results in the Activation of CD8+ T Cells J. Immunol., December 1, 2001; 167(11): 6462 - 6470. [Abstract] [Full Text] [PDF]

				R. Ignatius, K. Mahnke, M. Rivera, K. Hong, F. Isdell, R. M. Steinman, M. Pope, and L. Stamatatos Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo Blood, November 15, 2000; 96(10): 3505 - 3513. [Abstract] [Full Text] [PDF]

				N. Haicheur, E. Bismuth, S. Bosset, O. Adotevi, G. Warnier, V. Lacabanne, A. Regnault, C. Desaymard, S. Amigorena, P. Ricciardi-Castagnoli, et al. The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens J. Immunol., September 15, 2000; 165(6): 3301 - 3308. [Abstract] [Full Text] [PDF]

				R. S. McHugh, S. Nagarajan, Y.-C. Wang, K. W. Sell, and P. Selvaraj Protein Transfer of Glycosyl-phosphatidylinositol-B7-1 into Tumor Cell Membranes: A Novel Approach to Tumor Immunotherapy Cancer Res., May 1, 1999; 59(10): 2433 - 2437. [Abstract] [Full Text] [PDF]

				N. Maitre, J. M. Brown, M. Demcheva, J. R. Kelley, M. A. Lockett, J. Vournakis, and D. J. Cole Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination Clin. Cancer Res., May 1, 1999; 5(5): 1173 - 1182. [Abstract] [Full Text] [PDF]

				A. L. Marzo, R. A. Lake, B. W. S. Robinson, and B. Scott T-Cell Receptor Transgenic Analysis of Tumor-specific CD8 and CD4 Responses in the Eradication of Solid Tumors Cancer Res., March 1, 1999; 59(5): 1071 - 1079. [Abstract] [Full Text] [PDF]

				P. Shrikant and M. F. Mescher Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness J. Immunol., March 1, 1999; 162(5): 2858 - 2866. [Abstract] [Full Text] [PDF]